DiaMedica Therapeutics Files 2024 10-K
Ticker: DMAC · Form: 10-K · Filed: Mar 17, 2025 · CIK: 1401040
| Field | Detail |
|---|---|
| Company | Diamedica Therapeutics Inc. (DMAC) |
| Form Type | 10-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
DiaMedica's 2024 10-K is in. Check financials and strategy.
AI Summary
DiaMedica Therapeutics Inc. filed its 2024 10-K on March 17, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Minneapolis, MN, operates in the pharmaceutical preparations sector. Key financial details and operational highlights for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of DiaMedica's financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, DiaMedica faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period covered by the 10-K)
- 2025-03-17 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- DiaMedica Therapeutics Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-17 (date) — Filing date
- Minneapolis, MN (location) — Company headquarters
FAQ
What is the primary business of DiaMedica Therapeutics Inc.?
DiaMedica Therapeutics Inc. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code [2834].
When did DiaMedica Therapeutics Inc. change its name from DiaMedica Inc.?
The company's name change from DiaMedica Inc. to DiaMedica Therapeutics Inc. occurred on 2007-05-25.
What is the SEC file number for DiaMedica Therapeutics Inc.'s 10-K filing?
The SEC file number for this filing is 001-36291.
Where is DiaMedica Therapeutics Inc. headquartered?
DiaMedica Therapeutics Inc. is headquartered in Minneapolis, MN, with its business address at 301 Carlson Parkway, Suite 210.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending on 2024-12-31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding DiaMedica Therapeutics Inc. (DMAC).